The Chamber of Deputies approved this Wednesday (23) a bill that allows the Unified Health System (SUS) to prescribe and apply drugs with an indication of use different from that approved by the National Health Surveillance Agency (Anvisa). This permission is only valid if there is a recommendation from the National Commission for the Incorporation of Technologies in the SUS (Conitec). The matter goes to presidential sanction.
The project, authored by the Federal Senate, provides that scientific evidence on the efficacy, effectiveness and safety of the drug for the new use must be demonstrated, with standardization in a protocol established by the Ministry of Health.
The basic text of the PL was approved in the Chamber in December of last year, however the deputies still needed to vote on the highlights, which were rejected in today’s session.
* With information from the Câmara de Notícias Agency
